Thematic areas of research:
Image
To top
Unit
Cellular and Chemical Biology (UMR3666 / U1143)
The Curie Institute is a cancer research and care centre characterized by interdisciplinarity. The Cellular and Chemical Biology department cherishes this spirit by uniting within the same perimeter researchers from various backgrounds, notably organic chemistry and cell biology. It is our objective to address the timeliest challenges in life sciences and biomedicine from unique angles that become accessible due to a real integration between disciplines.
Teams
Key figures
11
awards/honours
2
ERC
21
publications with IF>20
Key publications
All publications
-
Glycolipid-dependent and lectin-driven transcytosis in mouse enterocytesCommunications Biology
-
CXCR6 deficiency impairs cancer vaccine efficacy and CD8+ resident memory T-cell recruitment in head and neck and lung tumorsJournal for ImmunoTherapy of Cancer
-
-
CD44 regulates epigenetic plasticity by mediating iron endocytosisNature Chemistry
-
Functional dissection of the retrograde Shiga toxin trafficking inhibitor Retro-2Nature Chemical Biology
-
News
All news
-
Drs. Renata Basto and Raphaël Rodriguez, winners of the CNRS Silver Medal 2024!Each year, the CNRS honors men and women who have made outstanding contributions to the dynamism of the institution and to the advancement of French research. For this 2024 edition, Dr. Renata Basto, head of the Biology of Centrosomes and Genetic Instability team, and Dr. Raphaël Rodriguez, head of the Chemical Biology team, are the proud winners of the CNRS Silver Medal.13/03/2024
-
Senescence and cancer cell plasticity: a high-risk connectionBy analyzing the response of human mammary epithelial cells to oncogenic activation, teams from Institut Curie and Centre Léon Bérard have highlighted the involvement of plasticity in the early phases of mammary tumorigenesis, and revealed its link with the senescence process. These results were published in Science Advances.27/02/2024
-
Dr. Raphaël Rodriguez awarded the Liliane Bettencourt Prize for Life SciencesDr. Raphaël Rodriguez, head of the Chemical Biology team (CNRS UMR3666 / Inserm U1143), has been named winner of the 2023 Liliane Bettencourt Prize for Life Sciences. This award recognizes his work on the design of small molecules to dissect cellular processes related to cancer, inflammation and aging.04/12/2023
-
Technological revolution: chemical innovation at the service of "Next-Generation Sequencing" (Next-Generation Sequencing = NGS)The result of solving a series of technological challenges, Next-Generation Sequencing (NGS) has revolutionized the work of the scientific community. Dr Raphael Rodriguez, head of the Chemical Biology team (CNRS UMR3666 / Inserm U1143) at Institut Curie tells the genesis in an article published in Nature Biotechnology on October 16th.16/11/2023
-
Inflammation and cancer: identifying the role of copper paves the way for new therapeutic applicationsFor the 1st time, researchers from Institut Curie, the CNRS and Inserm have uncovered a previously unknown chain of biochemical reactions. This chain involves copper and leads to metabolic and epigenetic alterations that activate inflammation and tumorigenesis. But there is more; the research team developed a “drug prototype” capable of mitigating both the mechanisms of inflammation and the processes potentially involved in metastatic spread. These results were published in the journal Nature on April 26, 2023.26/04/2023
-
The secret of an essential cell signaling pathway has finally been revealedA membrane receptor is like a lock, a ligand is like a key and when one binds to the other, cell activity is triggered. Although this relatively simple pattern often works, a team at Institut Curie has just revealed in Nature Cell Biology that it is not always as simple as that: for the JAK-STAT signaling pathway, vital in several pathologies, it all happens in the endosome.01/03/2023
Scientific events
All scientific events
15 Oct
2024
Seminar
11h-23h
Endocytic control of cell plasticity in cancer
Over the past two decades, there has been a significant shift in our understanding of the role of endocytosis and trafficking of signaling receptors. It has evolved from being viewed simply as a signal extinguisher (resulting in long-term attenuation) to being recognized as a sophisticated mechanism capable of delivering signals to specific cellular locations with precise timing. Therefore, endocy
26 Jan
2024
Symposium
08h-18h
1st Ferroptosis France symposium
For the 1st Ferroptosis France Symposium, the state of the art in Ferroptosis will be presented by world leaders to feature the latest innovations and future trends in this innovative and dynamic field.
28 Apr
2023
Seminar
11h-23h
Modern fluorophores and hypoxia targeting
Hypoxia (low oxygen levels) occurs in a range of biological contexts, including plants, bacterial biofilms, and solid tumors. It elicits responses from these biological systems that impact their survival, for example, hypoxia makes tumors more resistant to all forms of therapy and leads to poor patient prognosis. Furthermore, hypoxia in the tumor microenvironment is heterogeneous (with O2 ranging
12 Jan
2023
13 Jan
2023
Event
08h-19h
3rd PSL Chemical Biology Symposium
The 3rd PSL Chemical Biology symposium will take place in Paris at Institut Curie, from January 12-13, 2023.
An international meeting organized by Institut Curie, Chimie PSL University, Sorbonne University, Inserm and CNRS.
For the 3rd PSL Chemical Biology Symposium, the state of the art in chemical biology will again be presented by world leaders to feature the latest innovations and
An international meeting organized by Institut Curie, Chimie PSL University, Sorbonne University, Inserm and CNRS.
For the 3rd PSL Chemical Biology Symposium, the state of the art in chemical biology will again be presented by world leaders to feature the latest innovations and
9 Sep
2022
Seminar
10h-23h
Targeting chromatin regulators in cancer
A hallmark of all malignancies is transcriptional dysregulation, which is initiated by recurrent translocations and/or mutations in transcription factors and chromatin regulators. These genetic aberrations manifests as a block in differentiation and an increase in malignant self-renewal. They also facilitate the cancer’s ability to adapt rapidly to therapeutic pressure. These established fea